The Antibody Shared Resource (ASR) is a dedicated high-throughput facility for antibody generation and related technologies. At the time of the last competitive renewal, this shared resource received an """"""""Outstanding"""""""" rating. A major role for the ASR is to generate monoclonal (mAb) and polyclonal (pAb) antibodies and to make a broad range of antibody-related technologies cost effective and readily available to VICC investigators. For both mAb and pAb projects, the ASR offers end-to-end service that includes (1) antigen design, expression, and purification, (2) immunization and bleeding, and (3) protein-G (monoclonal) or antigen (polyclonal) affinity purification. Thus, investigators with no experience in the generation of antibodies can quickly and efficiently move a project forward. For monoclonal projects, ASR staff work closely with VICC investigators to ensure that the antibody screens are designed to capture antibodies tailored to their specific needs (e.g., immunoprecipitation, immunohistochemistry, receptor neutralization, etc). For polyclonal antibodies, aside from an initial consult, the ASR will handle the entire project, returning high quality affinity purified antibody. In addition, ASR staff provide a wide range of antibody support services including hybridoma subcloning, isotyping, ELISA screening, antibody scale up and large-scale production, antibody labeling (e.g., fluorophores, biotin, quantum dots, etc.), conjugation to affinity matrices (e.g., magnetic proteomic beads, sepharose), long-term hybridoma storage, and protein (antigen) design, expression, and purification. All shared resource services are offered at cost with rapid turnaround. Albert Reynolds, Ph.D., Professor of Cancer Biology with more than 20 years'experience with monoclonal antibody technology, directs this Resource as Scientific Director. Dr. Robert Carnahan, Research Assistant Professor of Cancer Biology, is the ASR Managing Director and oversees all aspects of daily operation. The staff is comprised of four technicians with specialized training in the full spectrum of services and methodologies provides by this resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-18
Application #
8733537
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
18
Fiscal Year
2014
Total Cost
$178,605
Indirect Cost
$89,303
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Marks, Christian R; Shonesy, Brian C; Wang, Xiaohan et al. (2018) Activated CaMKII? Binds to the mGlu5 Metabotropic Glutamate Receptor and Modulates Calcium Mobilization. Mol Pharmacol 94:1352-1362
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Pollins, Alonda C; Boyer, Richard B; Nussenbaum, Marlieke et al. (2018) Comparing Processed Nerve Allografts and Assessing Their Capacity to Retain and Release Nerve Growth Factor. Ann Plast Surg 81:198-202
Coppola, Jennifer J; Disney, Anita A (2018) Most calbindin-immunoreactive neurons, but few calretinin-immunoreactive neurons, express the m1 acetylcholine receptor in the middle temporal visual area of the macaque monkey. Brain Behav 8:e01071
Hull, P C; Buchowski, M; Canedo, J R et al. (2018) Childhood obesity prevention cluster randomized trial for Hispanic families: outcomes of the healthy families study. Pediatr Obes 13:686-696
Fensterheim, Benjamin A; Young, Jamey D; Luan, Liming et al. (2018) The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism. J Immunol 200:3777-3789
Covington, Brett C; Spraggins, Jeffrey M; Ynigez-Gutierrez, Audrey E et al. (2018) Response of Hypogean Actinobacterial Genera Secondary Metabolism to Chemical and Biological Stimuli. Appl Environ Microbiol :
Hong, Jun; Maacha, Selma; Belkhiri, Abbes (2018) Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma. Mol Oncol 12:2191-2208
Dahlman, Kimberly Brown; Weinger, Matthew B; Lomis, Kimberly D et al. (2018) Integrating Foundational Sciences in a Clinical Context in the Post-Clerkship Curriculum. Med Sci Educ 28:145-154
Ramsey, Haley E; Fischer, Melissa A; Lee, Taekyu et al. (2018) A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia. Cancer Discov 8:1566-1581

Showing the most recent 10 out of 2462 publications